Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 104617373 | 10461737 | 3 | F | 2014 | 20160826 | 20140918 | 20160902 | EXP | JP-SA-2014SA125006 | AVENTIS | 66.00 | YR | E | M | Y | 0.00000 | 20160902 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 104617373 | 10461737 | 1 | PS | RENAGEL | SEVELAMER HYDROCHLORIDE | 1 | Oral | U | UNKNOWN | 21179 | 4.5 | G | TABLET | QD | |||||
| 104617373 | 10461737 | 2 | SS | KAYEXALATE | SODIUM POLYSTYRENE SULFONATE | 1 | Unknown | U | UNKNOWN | 0 | 10 | G | QD | ||||||
| 104617373 | 10461737 | 3 | C | CALCIUM POLYSTYRENE SULFONATE | CALCIUM POLYSTYRENE SULFONATE | 1 | Oral | 0 | 5 | G | BID | ||||||||
| 104617373 | 10461737 | 4 | C | LASIX | FUROSEMIDE | 1 | Oral | 0 | 40 | MG | TABLET | QD | |||||||
| 104617373 | 10461737 | 5 | C | CALFINA | ALFACALCIDOL | 1 | Oral | 0 | .5 | UG | TABLET | QD | |||||||
| 104617373 | 10461737 | 6 | C | PERSANTINE | DIPYRIDAMOLE | 1 | Oral | 0 | 300 | MG | CAPSULE | QD | |||||||
| 104617373 | 10461737 | 7 | C | PROTECADIN | LAFUTIDINE | 1 | Oral | 0 | 5 | MG | TABLET | BID | |||||||
| 104617373 | 10461737 | 8 | C | CALTAN | CALCIUM CARBONATE | 1 | Oral | 0 | 1000 | MG | TABLET | TID | |||||||
| 104617373 | 10461737 | 9 | C | ZYLORIC | ALLOPURINOL | 1 | Oral | 0 | 100 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 104617373 | 10461737 | 1 | Hyperphosphataemia |
| 104617373 | 10461737 | 2 | Hyperkalaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 104617373 | 10461737 | OT |
| 104617373 | 10461737 | DS |
| 104617373 | 10461737 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 104617373 | 10461737 | Abdominal distension | |
| 104617373 | 10461737 | Abdominal pain | |
| 104617373 | 10461737 | Abdominal rigidity | |
| 104617373 | 10461737 | Ascites | |
| 104617373 | 10461737 | Coma scale abnormal | |
| 104617373 | 10461737 | Large intestine perforation | |
| 104617373 | 10461737 | Tenderness |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |